Work

Checkpoint Inhibitors in Lung Cancer Are Not Immune from Cost-Effectiveness Analysis

Year: 2016

Type: editorial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.07.028

Authors: Ronan J. Kelly, Thomas J. Smith

Institutions: Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Eli Lilly and Company

OpenAlex ID: W2536172562

Cites: 13

Cited by: 12

Related to: 10